Switch to remote audits

Even under pandemic conditions, compliance monitoring of partners and vendors is possible. QFINITY helped a medium-sized pharmaceutical company switch its pharmacovigilance audit program from an on-site to a remote audit model. With travel restrictions in place, QFINITY is supporting the same manufacturer in conducting remote audits to monitor pharmacovigilance agreements with partners worldwide. The switch from “on-site” to remote audits followed a thorough risk assessment in response to the Covid-19 pandemic.